Table 7.
BS (cfu/kg) |
0 |
5 × 108 |
0 |
5 × 108 |
Pooled SEM |
P-value |
||
---|---|---|---|---|---|---|---|---|
MMT (g/kg) | 0 | 0 | 0.5 | 0.5 | BS | MMT | BS × MMT | |
Duodenum | ||||||||
Claudin-1 | 1.00 | 1.04 | 1.53 | 0.97 | 0.13 | 0.374 | 0.413 | 0.261 |
Occludin | 1.00 | 0.96 | 1.12 | 1.09 | 0.08 | 0.842 | 0.461 | 0.981 |
ZO-1 | 1.00 | 1.00 | 1.07 | 0.95 | 0.08 | 0.722 | 0.945 | 0.743 |
TLR2 | 1.00 | 0.92 | 0.96 | 0.61 | 0.09 | 0.257 | 0.351 | 0.462 |
TLR4 | 1.00a | 0.67a | 1.02a | 0.26b | 0.09 | <0.001 | 0.089 | 0.074 |
MyD88 | 1.00a | 0.64b | 0.73b | 0.69b | 0.04 | 0.011 | 0.144 | 0.041 |
NF-κB p65 | 1.00 | 0.94 | 0.96 | 0.90 | 0.07 | 0.707 | 0.787 | 0.987 |
IL-1β | 1.00a | 0.41c | 0.75a,b | 0.51b,c | 0.07 | <0.001 | 0.472 | 0.110 |
TNF-α | 1.00 | 0.86 | 1.34 | 0.89 | 0.08 | 0.059 | 0.223 | 0.312 |
Jejunum | ||||||||
Claudin-1 | 1.00 | 0.82 | 0.85 | 0.90 | 0.09 | 0.733 | 0.844 | 0.569 |
Occludin | 1.00a | 0.55b | 0.94a | 1.23a | 0.08 | 0.514 | 0.020 | 0.007 |
ZO-1 | 1.00 | 0.56 | 0.88 | 0.94 | 0.07 | 0.147 | 0.312 | 0.065 |
TLR2 | 1.00 | 0.76 | 0.55 | 0.78 | 0.09 | 0.987 | 0.288 | 0.231 |
TLR4 | 1.00a,b | 0.66b,c | 1.16a | 0.39c | 0.10 | 0.002 | 0.718 | 0.191 |
MyD88 | 1.00a | 0.70b | 0.66b | 0.61b | 0.05 | 0.031 | 0.010 | 0.097 |
NF-κB p65 | 1.00 | 0.52 | 0.81 | 0.68 | 0.07 | 0.030 | 0.906 | 0.198 |
IL-1β | 1.00 | 0.77 | 0.73 | 0.96 | 0.09 | 0.993 | 0.814 | 0.231 |
TNF-α | 1.00 | 0.92 | 1.19 | 0.79 | 0.06 | 0.025 | 0.754 | 0.131 |
a–cMeans within a row with different superscripts differ significantly (P < 0.05).
Means represent 6 replicates per treatment, with 1 hen per replicate.
Expressed in arbitrary units. The mRNA level of each target gene for the treatment group fed with the basal diet was assigned a value of 1 and normalized against beta-actin.
ZO-1: zonula occludens-1; TLR2: toll-like receptor 2; TLR4: toll-like receptor 4; MyD88: myeloid differentiation factor 88; NF-κB P65: nuclear factor kappa B P65; IL-1β: interleukin 1 beta; TNF-α: tumor necrosis factor alpha.